ゼリア新薬工業の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/01/15 | 2,216 | 2,220 | 2,190 | 2,207 | -18 | -0.8% | 49,300 |
| 2025/01/14 | 2,241 | 2,241 | 2,208 | 2,225 | -26 | -1.2% | 50,000 |
| 2025/01/10 | 2,257 | 2,267 | 2,245 | 2,251 | -30 | -1.3% | 32,700 |
| 2025/01/09 | 2,295 | 2,298 | 2,273 | 2,281 | -29 | -1.3% | 36,700 |
| 2025/01/08 | 2,310 | 2,318 | 2,288 | 2,310 | -3 | -0.1% | 63,200 |
| 2025/01/07 | 2,339 | 2,341 | 2,311 | 2,313 | -26 | -1.1% | 65,400 |
| 2025/01/06 | 2,433 | 2,433 | 2,330 | 2,339 | -103 | -4.2% | 89,400 |
| 2024/12/30 | 2,453 | 2,464 | 2,424 | 2,442 | -8 | -0.3% | 45,300 |
| 2024/12/27 | 2,438 | 2,450 | 2,420 | 2,450 | +40 | +1.7% | 48,100 |
| 2024/12/26 | 2,425 | 2,425 | 2,392 | 2,410 | +2 | +0.1% | 44,600 |
| 2024/12/25 | 2,450 | 2,450 | 2,387 | 2,408 | -30 | -1.2% | 34,000 |
| 2024/12/24 | 2,415 | 2,447 | 2,415 | 2,438 | +7 | +0.3% | 24,600 |
| 2024/12/23 | 2,402 | 2,440 | 2,402 | 2,431 | +25 | +1% | 34,300 |
| 2024/12/20 | 2,432 | 2,452 | 2,406 | 2,406 | -40 | -1.6% | 85,000 |
| 2024/12/19 | 2,378 | 2,455 | 2,372 | 2,446 | +39 | +1.6% | 37,200 |
| 2024/12/18 | 2,466 | 2,485 | 2,404 | 2,407 | -48 | -2% | 53,400 |
| 2024/12/17 | 2,473 | 2,505 | 2,452 | 2,455 | -12 | -0.5% | 60,400 |
| 2024/12/16 | 2,450 | 2,473 | 2,426 | 2,467 | +16 | +0.7% | 28,400 |
| 2024/12/13 | 2,400 | 2,455 | 2,400 | 2,451 | +16 | +0.7% | 66,400 |
| 2024/12/12 | 2,440 | 2,444 | 2,410 | 2,435 | +9 | +0.4% | 39,600 |
| 2024/12/11 | 2,424 | 2,443 | 2,401 | 2,426 | +2 | +0.1% | 33,800 |
| 2024/12/10 | 2,457 | 2,479 | 2,420 | 2,424 | -11 | -0.5% | 57,700 |
| 2024/12/09 | 2,405 | 2,448 | 2,395 | 2,435 | +39 | +1.6% | 87,400 |
| 2024/12/06 | 2,362 | 2,396 | 2,362 | 2,396 | +40 | +1.7% | 54,100 |
| 2024/12/05 | 2,343 | 2,364 | 2,329 | 2,356 | +13 | +0.6% | 30,500 |
| 2024/12/04 | 2,362 | 2,368 | 2,323 | 2,343 | -31 | -1.3% | 38,800 |
| 2024/12/03 | 2,330 | 2,383 | 2,315 | 2,374 | +51 | +2.2% | 58,300 |
| 2024/12/02 | 2,350 | 2,350 | 2,288 | 2,323 | -2 | -0.1% | 48,100 |
| 2024/11/29 | 2,308 | 2,339 | 2,297 | 2,325 | +33 | +1.4% | 70,300 |
| 2024/11/28 | 2,257 | 2,292 | 2,254 | 2,292 | +54 | +2.4% | 43,200 |
| 2024/11/27 | 2,251 | 2,262 | 2,225 | 2,238 | -19 | -0.8% | 31,700 |
| 2024/11/26 | 2,241 | 2,260 | 2,234 | 2,257 | +16 | +0.7% | 34,900 |
| 2024/11/25 | 2,270 | 2,274 | 2,241 | 2,241 | -3 | -0.1% | 60,800 |
| 2024/11/22 | 2,239 | 2,252 | 2,222 | 2,244 | +23 | +1% | 37,100 |
| 2024/11/21 | 2,238 | 2,247 | 2,221 | 2,221 | +5 | +0.2% | 24,500 |
| 2024/11/20 | 2,222 | 2,236 | 2,215 | 2,216 | ±0 | ±0% | 29,900 |
| 2024/11/19 | 2,226 | 2,227 | 2,210 | 2,216 | ±0 | ±0% | 23,100 |
| 2024/11/18 | 2,203 | 2,236 | 2,203 | 2,216 | -13 | -0.6% | 27,600 |
| 2024/11/15 | 2,256 | 2,256 | 2,220 | 2,229 | -2 | -0.1% | 26,600 |
| 2024/11/14 | 2,260 | 2,265 | 2,231 | 2,231 | -29 | -1.3% | 37,800 |
| 2024/11/13 | 2,236 | 2,271 | 2,230 | 2,260 | +20 | +0.9% | 61,100 |
| 2024/11/12 | 2,229 | 2,258 | 2,229 | 2,240 | +19 | +0.9% | 54,900 |
| 2024/11/11 | 2,217 | 2,230 | 2,203 | 2,221 | +4 | +0.2% | 46,000 |
| 2024/11/08 | 2,274 | 2,279 | 2,204 | 2,217 | -38 | -1.7% | 91,700 |
| 2024/11/07 | 2,239 | 2,298 | 2,221 | 2,255 | -117 | -4.9% | 229,100 |
| 2024/11/06 | 2,372 | 2,397 | 2,348 | 2,372 | -3 | -0.1% | 95,200 |
| 2024/11/05 | 2,315 | 2,411 | 2,297 | 2,375 | +71 | +3.1% | 209,900 |
| 2024/11/01 | 2,315 | 2,330 | 2,294 | 2,304 | -26 | -1.1% | 44,300 |
| 2024/10/31 | 2,341 | 2,360 | 2,313 | 2,330 | +4 | +0.2% | 77,300 |
| 2024/10/30 | 2,343 | 2,347 | 2,316 | 2,326 | +4 | +0.2% | 283,300 |
151～
200
件表示中 / 3769件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ゼリア新薬 | 206,000円 | +3.1% | -6.5% | 2.33% | 9.56倍 | 1.01倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ジーエヌアイ | 274,000円 | +21.7% | +999.9% | 0.00% | 12.62倍 | 4.32倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 持田薬 | 318,500円 | +5.1% | -7.0% | 2.51% | 20.91倍 | 0.86倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 杏林製薬 | 154,600円 | -2.4% | -52.3% | 3.69% | 18.50倍 | 0.65倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 238,900円 | +4.1% | -3.1% | 2.43% | 20.75倍 | 1.81倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム
